Menu

Notable Science Quotes

Nobel's diversity problem, Brexit and science, letters of recommendation skew sexist, and NIH's public perception troubles

Nov 1, 2016
The Scientist Staff

© ROMAN SIGAEV/SHUTTERSTOCK.COM

Eventually, it becomes hard to take the selections seriously, because we have no idea what factors are taken into consideration, except that somehow, it ends with only white and Asian men receiving the prize.

Chanda Prescod-Weinstein, a theoretical astrophysicist at the University of Washington in Seattle, on the lack of diversity
among science Nobel laureates (LiveScience, October 5)

 

As wonderful as it is to advance physics, chemistry, physiology or medicine, it’s at least as wonderful to tackle environmental problems, predict natural disasters, demystify how species interact, and educate a population to grapple with complex and important scientific topics. The Nobel organization should take a bold leap into the present and shine its bright light more widely—and unshackle itself from
 a 19th-century vision of what makes good science.

Gabriel Popkin, science and environmental writer, in a New York Times op-ed on the need to expand the categories for which the Nobel Prize is awarded (October 3)

 

The support (from my cash prize) would last only five years at most. It is important to put in place a permanent system that assists young researchers.

—Cell biologist Yoshinori Ohsumi of the Tokyo Institute of Technology, on his decision to use his $930,000 Nobel Prize winnings to set up a fund for scholarships and research grants for young researchers (The Asahi Shimbun, October 4)

 

I am very disturbed by the talk coming out of the U.K. at the moment. Anything that stops the free movement of people is a big negative for science.

Sir Fraser Stoddart, a Scottish chemist who was awarded a Nobel prize last month for his work on molecular nanomachines, on the potential harm the Brexit may have on research (The Guardian, October 6)

 

A source of common frustration for people at the NIH is to realize that in general the public doesn’t understand that the money that goes into the NIH ends up supporting scientists whose work has widespread public benefit and that the advances that occur can frequently be traced back to discoveries that were made 10, 20, 30, 40 years earlier.

—Cancer researcher Harold Varmus, former director of the National Cancer Institute, in answer to a question about the pace at which science goes from basic research to clinical relevance (Undark, September 20)

 

We’re not trying to assign blame or criticize anyone or call anyone consciously sexist. Rather the point is to use the results of this study to open up meaningful dialogues on implicit gender bias, be it at a departmental level or an institutional level or even a discipline level.

Kuheli Dutt, a social scientist and diversity officer at Columbia University, on her Nature Geoscience study of hundreds of postdoc letters of recommendation that found female applicants were only half as likely to get superlative letters as their male counterparts
(Scientific American, October 6)

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.